Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

NCT02417142 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT02417142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02417142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
Lead sponsor
University of Massachusetts, Worcester
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
July 31, 2020
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia